Cargando…
Targeting tumor-associated macrophages to synergize tumor immunotherapy
The current treatment strategies in advanced malignancies remain limited. Notably, immunotherapies have raised hope for a successful control of these advanced diseases, but their therapeutic responses are suboptimal and vary considerably among individuals. Tumor-associated macrophages (TAMs) are a m...
Autores principales: | Xiang, Xiaonan, Wang, Jianguo, Lu, Di, Xu, Xiao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7900181/ https://www.ncbi.nlm.nih.gov/pubmed/33619259 http://dx.doi.org/10.1038/s41392-021-00484-9 |
Ejemplares similares
-
Tumor-associated macrophage-related strategies for glioma immunotherapy
por: Tang, Fansong, et al.
Publicado: (2023) -
Polyoxazoline‐Based Nanovaccine Synergizes with Tumor‐Associated Macrophage Targeting and Anti‐PD‐1 Immunotherapy against Solid Tumors
por: Matos, Ana I., et al.
Publicado: (2023) -
Targeting immune checkpoints on tumor-associated macrophages in tumor immunotherapy
por: Xu, Shumin, et al.
Publicado: (2023) -
Targeting Tumor-Associated Macrophages in Cancer Immunotherapy
por: Petty, Amy J., et al.
Publicado: (2021) -
Immunotherapy Targeting Tumor-Associated Macrophages
por: Liu, Yafei, et al.
Publicado: (2020)